Edmund J. Pezalla, MD,

Articles by Edmund J. Pezalla, MD,

Participating Faculty: Research to Real World Application: Experts Weigh In on the Underuse of Anticoagulants

ByJan Berger, MD, MJ,Donald C. Balfour III, MD, FACP,Joseph E. Biskupiak, PhD, MBA,Jeffrey D. Dunn, PharmD, MBA,Dennis B. Liotta, MD, MBA,Geno J. Merli, MD, FACP, FHM, FSVM,Edmund J. Pezalla, MD,

December 26th 2014

Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

ByJan Berger, MD, MJ,Donald C. Balfour III, MD, FACP,Joseph E. Biskupiak, PhD, MBA,Jeffrey D. Dunn, PharmD, MBA,Dennis B. Liotta, MD, MBA,Geno J. Merli, MD, FACP, FHM, FSVM,Edmund J. Pezalla, MD,

December 26th 2014

This article is the first in a 2-part series that summarizes the proceedings from a roundtable meeting that was conducted to discuss real-world considerations in nonvalvular atrial fibrillation and venous thromboembolism.

Latest Updated Articles

Participating Faculty: Research to Real World Application: Experts Weigh In on the Underuse of Anticoagulants
Published: December 26th 2014 | Updated:
Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants
Published: December 26th 2014 | Updated:

Edmund J. Pezalla, MD,

Articles by Edmund J. Pezalla, MD,

Participating Faculty: Research to Real World Application: Experts Weigh In on the Underuse of Anticoagulants

Research to Real-World Application: Experts Weigh In on the Underuse of Anticoagulants

Latest Updated Articles

Trending on AJMC

Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure

FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes

Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?

Counseling Patients With OSA on Side Effects of GLP-1s: Matthew Biszewski, PharmD

Body Size, Metabolism Impact Psoriasis Severity and Biologic Response